C Ray's JPM Week: Connecting the Global Ecosystem, Advancing the Industry Future
The J.P. Morgan Healthcare Conference, an annual tone-setter for the industry, will be held at the Westin St. Francis Hotel in San Francisco from January 12 to 15, 2026. It is expected to attract over 8,000 global participants during the main conference period, including representatives from multinational corporations, innovative biotech firms, investment institutions, technology platform companies, and policy-making bodies. This event stands as a high-intensity global hub for business development, investment, and cross-border collaboration.
Building on this occasion, C Ray will initiate a series of business exchanges and partner visits in San Francisco and other U.S. cities starting January 11, formally launching its international cooperation efforts for the year 2026.
First Stop: Pre-conference Specialized Seminar
The 9th BFC Healthcare International Business Cooperation and Investment Symposium
Prior to the official start of the JPM main conference, C Ray will attend the 9th BFC Healthcare International Business Cooperation and Investment Symposium. This symposium, held on January 11 at the St. Regis Hotel in San Francisco, is recognized as one of the premier satellite events during JPM Week, serving as a vital platform for investors and innovative enterprises to connect and explore opportunities.
BFC Group is a boutique investment bank specializing in the global biopharmaceutical industry, renowned for its expertise in cross-border business development, financing advisory, and strategic partnerships.
-
VIP Networking Lunch ：13:00-14:00
As one of this year's conference partners, C Ray is honored to sponsor the symposium's VIP Networking Lunch. The event will gather approximately 200 attendees from around the globe—including senior executives from pharmaceutical companies, biotech innovators, multinational decision-makers, and investors—to provide a warm and relaxed environment for dining and conversation.
Amidst the intensive conference schedule, we hope this gathering will become a welcoming space where participants can pause and recharge, engage in meaningful dialogue, and foster shared insights. More than just a meal, this lunch represents C Ray's sincere effort to connect genuinely with global industry partners during JPM Week and to collectively contribute to a vibrant ecosystem.
-
Corporate Showcase：14:15-14:30
Following the luncheon, C Ray will take the stage to share its practical experience and insights in cross-border early-stage development. As the global epicentre of first-in-class innovation, the United States is home to a dynamic ecosystem of small and mid-sized biotech companies—a key engine driving cutting-edge breakthroughs.
C Ray aims to build a reliable and efficient translation bridge between these high-potential sources of innovation and markets in China and across Asia. Our goal is to support scientific breakthroughs in navigating the early-stage "valley of death," systematically advancing projects toward key validation milestones.
Second Stop: Intensive Global Networking
Bio Partnering Meetings and Visits with Global Partners
During the JPM conference and the following week, the C Ray team will continue to engage in business meetings and visits with global partners in San Francisco and surrounding cities. These face-to-face discussions will be open and explorative, covering diverse models such as cross-border CDMO services, co-development initiatives, and business development collaborations.
Both inside and outside the conference venues, C Ray will maintain a professional and dedicated approach, facilitating efficient dialogue with key partners across the R&D, translation, production, and supply chain sectors. Together, we aim to clarify collaboration pathways and align critical resources.
We believe that in-depth, face-to-face communication is the foundation of trust. Taking JPM Week as an opportunity, we look forward to strengthening our connections with the global radiopharmaceutical ecosystem in San Francisco this January, exploring more valuable paths for collaboration, and jointly advancing the innovation and translation of radiopharmaceuticals.
Complete Conference Itinerary:
Introduction to C Ray Therapeutics
C Ray Therapeutics is dedicated to delivering end-to-end solutions for innovative radiopharmaceuticals to clients around the world. Our services span process development, quality research, preclinical evaluation, IND Enabling, clinical supply, and commercial scale cGMP production, all backed by a reliable, robust logistics network. As of 2024, we have raised over USD 187 million in total funding.
As a dedicated CRDMO partner in radiopharmaceuticals, one of our core strengths is a stable, diversified supply of radionuclides. We are actively developing high-quality domestic sources while playing a leading role in integrating and fortifying the global supply chain—most notably securing access to challenging isotopes such as Ac-225. To date, we have supported the development of 16 Ac-225–labeled projects.
Committed to empowering the industry, C Ray Therapeutics is building an open, integrated “production–academia–research–application” platform. By pooling resources across the value chain and pioneering critical radiopharmaceutical technologies, we accelerate the clinical translation of integrated diagnostic & therapeutic solutions. Our goal is to drive innovation and industrial upgrading in the radiopharmaceutical sector, establishing ourselves as a global benchmark in the field.
